|
IKZF5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62625468647093E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27675647831893E-14 |
| Normal-vs-Stage2 |
1.22257759471722E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
6.66133814775094E-16 |
| Stage1-vs-Stage2 |
5.917000E-01 |
| Stage1-vs-Stage3 |
3.520000E-02 |
| Stage1-vs-Stage4 |
5.722300E-02 |
| Stage2-vs-Stage3 |
3.631200E-01 |
| Stage2-vs-Stage4 |
3.012000E-01 |
| Stage3-vs-Stage4 |
7.923600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.88178419700125E-16 |
| Normal-vs-AfricanAmerican |
1.00830000016039E-07 |
| Normal-vs-Asian |
2.26441088102547E-12 |
| Caucasian-vs-AfricanAmerican |
3.444200E-01 |
| Caucasian-vs-Asian |
4.604800E-01 |
| AfricanAmerican-vs-Asian |
7.166600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
1.62792002100787E-12 |
| Male-vs-Female |
3.092600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.63122856836162E-14 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(81-100Yrs) |
4.30329999999701E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.828390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.198800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.307600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.747000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.479800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.693200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.823570E-04 |
| Classical-VS-Follicular |
4.081000E-01 |
| Classical-VS-Other |
5.526200E-01 |
| Classical-VS-Normal |
1.8366419496374E-12 |
| Tall-VS-Follicular |
1.208120E-02 |
| Tall-VS-Other |
2.837400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.843400E-01 |
| Follicular-VS-Normal |
1.62592161956354E-12 |
| Other-VS-Normal |
2.040700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.92068583260152E-14 |
| N0-vs-N1 |
5.486000E-01 |
|
|
